Profilo rischio-beneficio dei farmaci biologici nella pratica reumatologica. Da ANTARES a MonitorNet

Translated title of the contribution: The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet

Paolo Sfriso, F. Salaffi, S. Bombardieri, B. Canesi, C. M. Montecucco, S. Todesco

Research output: Contribution to journal › Article › peer-review

Translated title of the contribution	The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet
Original language	Italian
Pages (from-to)	77-84
Number of pages	8
Journal	Reumatismo
Volume	60
Issue number	2
Publication status	Published - 2008

ASJC Scopus subject areas

@article{9f48519c187b4a0c92a7d726f9b03475,

title = "Profilo rischio-beneficio dei farmaci biologici nella pratica reumatologica. Da ANTARES a MonitorNet",

author = "Paolo Sfriso and F. Salaffi and S. Bombardieri and B. Canesi and Montecucco, {C. M.} and S. Todesco",

year = "2008",

language = "Italian",

volume = "60",

pages = "77--84",

journal = "Reumatismo",

issn = "0048-7449",

publisher = "PAGEPRESS PUBL",

number = "2",

}

TY - JOUR

T1 - Profilo rischio-beneficio dei farmaci biologici nella pratica reumatologica. Da ANTARES a MonitorNet

AU - Sfriso, Paolo

AU - Salaffi, F.

AU - Bombardieri, S.

AU - Canesi, B.

AU - Montecucco, C. M.

AU - Todesco, S.

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=55249089999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249089999&partnerID=8YFLogxK

M3 - Articolo

C2 - 18651050

AN - SCOPUS:55249089999

VL - 60

SP - 77

EP - 84

JO - Reumatismo

JF - Reumatismo

SN - 0048-7449

IS - 2

ER -